Company LeMaitre Vascular, Inc.

Equities

LMAT

US5255582018

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-05-17 pm EDT 5-day change 1st Jan Change
78.45 USD +0.99% Intraday chart for LeMaitre Vascular, Inc. +3.05% +38.21%

Business Summary

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.

Number of employees: 622

Sales per Business

USD in Million2022Weight2023Weight Delta
Medical Devices and Human Tissue Cryopreservation
100.0 %
162 100.0 % 193 100.0 % +19.69%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
60.9 %
99 61.5 % 118 60.9 % +18.45%
Europe, Middle East and Africa
15.0 %
31 18.9 % 29 15.0 % -4.94%
Germany
6.9 %
11 6.9 % 13 6.9 % +19.58%
Asia Pacific
6.2 %
10 6.4 % 12 6.2 % +16.60%
Canada
5.6 %
8 5.2 % 11 5.6 % +29.39%
United Kingdom
4.4 %
-- 9 4.4 % -
Americas
0.9 %
2 1.0 % 2 0.9 % +4.33%

Managers

Managers TitleAgeSince
Chief Executive Officer 59 92-05-31
President 60 96-12-31
Director of Finance/CFO 59 04-12-31
Chief Tech/Sci/R&D Officer 46 01-12-31
Chief Operating Officer 53 96-12-31
Chief Tech/Sci/R&D Officer 50 95-12-31
Public Communications Contact - -
Human Resources Officer 42 19-12-31
Corporate Officer/Principal 48 03-12-31
Sales & Marketing 51 02-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 58 14-04-08
Director of Finance/CFO 59 04-12-31
Director/Board Member 76 08-09-16
Director/Board Member 66 02-12-31
Chief Executive Officer 59 92-05-31
President 60 96-12-31
Director/Board Member 68 22-09-20
Director/Board Member 59 20-04-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 24,036,471 20,346,053 ( 84.65 %) 1,590,362 ( 6.616 %) 84.65 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
14.43 %
3,223,084 14.43 % 203 M $
1,998,334 8.946 % 126 M $
Conestoga Capital Advisors LLC
8.653 %
1,932,917 8.653 % 122 M $
Vanguard Fiduciary Trust Co.
6.956 %
1,553,834 6.956 % 98 M $
Copeland Capital Management LLC
5.779 %
1,290,893 5.779 % 81 M $
Janus Henderson Investors US LLC
4.279 %
955,768 4.279 % 60 M $
Ranger Investment Management LP
3.688 %
823,713 3.688 % 52 M $
793,135 3.551 % 50 M $
Congress Asset Management Co. LLP
2.982 %
666,083 2.982 % 42 M $
Dimensional Fund Advisors LP
2.965 %
662,281 2.965 % 42 M $

Company contact information

LeMaitre Vascular, Inc.

63 Second Avenue

01803, Burlington

+781 221 2266

http://www.lemaitre.com
address LeMaitre Vascular, Inc.(LMAT)
  1. Stock Market
  2. Equities
  3. LMAT Stock
  4. Company LeMaitre Vascular, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW